1. Home
  2. WST vs TROW Comparison

WST vs TROW Comparison

Compare WST & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$361.16

Market Cap

23.9B

Sector

Health Care

ML Signal

HOLD

Logo T. Rowe Price Group Inc.

TROW

T. Rowe Price Group Inc.

HOLD

Current Price

$104.18

Market Cap

26.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
TROW
Founded
1923
1937
Country
United States
United States
Employees
N/A
4802
Industry
Medical/Dental Instruments
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
23.9B
26.1B
IPO Year
2004
2000

Fundamental Metrics

Financial Performance
Metric
WST
TROW
Price
$361.16
$104.18
Analyst Decision
Buy
Sell
Analyst Count
7
11
Target Price
$325.86
$98.00
AVG Volume (30 Days)
350.9K
1.2M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.30%
5.18%
EPS Growth
1.49
0.98
EPS
4.07
5.10
Revenue
$2,886,900,000.00
$2,370,700,000.00
Revenue This Year
$6.76
$5.48
Revenue Next Year
$6.22
$1.56
P/E Ratio
$90.06
$20.16
Revenue Growth
1.95
26.65
52 Week Low
$223.83
$85.22
52 Week High
$386.00
$122.00

Technical Indicators

Market Signals
Indicator
WST
TROW
Relative Strength Index (RSI) 62.59 30.80
Support Level $346.45 $101.55
Resistance Level $367.66 $107.09
Average True Range (ATR) 7.91 1.98
MACD 2.74 -0.59
Stochastic Oscillator 80.35 22.24

Price Performance

Historical Comparison
WST
TROW

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TROW T. Rowe Price Group Inc.

T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.

Share on Social Networks: